Cargando…

Is CD1a involved in antitumour immune responses during carcinogenesis?

Detalles Bibliográficos
Autor principal:	Cappello, F
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410177/ https://www.ncbi.nlm.nih.gov/pubmed/14970877 http://dx.doi.org/10.1038/sj.bjc.6601597

Ejemplares similares

Reply: Is CD1a involved in antitumour immune responses during carcinogenesis?
por: Coventry, B J, et al.
Publicado: (2004)

CD74 and HLA-DRA in Cervical Carcinogenesis: Potential Targets for Antitumour Therapy
por: Balakrishnan, Carol K., et al.
Publicado: (2022)

The role of aspirin in carcinogenesis
por: Caine, G J, et al.
Publicado: (2002)

Osteopontin and oral carcinogenesis
por: Kapoor, Shailendra
Publicado: (2008)

Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1
por: Leclerc, Marine, et al.
Publicado: (2019)

DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
por: Dan, Huimin, et al.
Publicado: (2019)

The mysterious steps in carcinogenesis: addendum
por: Brash, D, et al.
Publicado: (2009)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Fluoride carcinogenesis: The jury is still out!
por: Bajpai, Jyoti
Publicado: (2013)

Lysophosphatidic acid in carcinogenesis and tumor development
por: Albrecht, Wiebke
Publicado: (2018)

Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
por: Gilabert-Oriol, Roger, et al.
Publicado: (2018)

Functionalisation of Virus-Like Particles Enhances Antitumour Immune Responses
por: Kramer, Katrin, et al.
Publicado: (2019)

Spontaneous Physical Activity in Obese Condition Favours Antitumour Immunity Leading to Decreased Tumour Growth in a Syngeneic Mouse Model of Carcinogenesis
por: Le Guennec, Delphine, et al.
Publicado: (2021)

A new systems approach to combat arsenic induced carcinogenesis
por: Pyne, Saumyadipta, et al.
Publicado: (2013)

Testin and its emerging modulatory role in systemic carcinogenesis
por: Kapoor, Shailendra
Publicado: (2012)

Study of the antitumour effects and the modulation of immune response by histamine in breast cancer
por: Nicoud, Melisa B., et al.
Publicado: (2019)

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma
por: Figueiredo, Carlos R., et al.
Publicado: (2018)

STIM1 and STIM2-mediated Ca(2+) influx regulates antitumour immunity by CD8(+) T cells
por: Weidinger, Carl, et al.
Publicado: (2013)

Activation of cytotoxic T cell population and inversion of CD4:CD8 ratio as manifestations of cellular immune response in SARS-COV-2 infection
por: Khan, Fahad, et al.
Publicado: (2020)

The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics
por: Sheikh, Asfandyar, et al.
Publicado: (2014)

Multiple Numerical Chromosome Aberrations in Carcinogenesis: The Kidney Cancer Model
por: Teixeira, Manuel R.
Publicado: (2009)

Calcium signaling: an underlying link between cardiac disease and carcinogenesis
por: Xu, Xuehong, et al.
Publicado: (2018)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts
por: Kato, Ryoji, et al.
Publicado: (2020)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

Bacteria flying under the radar: linking a bacterial infection to colon carcinogenesis
por: Keenan, Jacqueline I, et al.
Publicado: (2014)

Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response
por: Yang, Mu-qing, et al.
Publicado: (2018)

Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
por: Arroyo-Sánchez, Daniel, et al.
Publicado: (2023)

In response to Sharing different perspectives to understand asbestos‐induced carcinogenesis: A comment to Jiang et al. (2016) by Alessandro Francesco Gualtieri (2017)
por: Toyokuni, Shinya, et al.
Publicado: (2017)

CD44 is involved in liver regeneration through enhanced uptake of extracellular cystine
por: Kim, Hyun Young, et al.
Publicado: (2022)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
por: Kay, Emily J., et al.
Publicado: (2023)

In Response
por: Humphries, Debbie, et al.
Publicado: (2011)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
por: Shin, Jung Min, et al.
Publicado: (2021)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Nasopharyngeal Haemophilus and local immune response during infant respiratory syncytial virus infection
por: Shilts, Meghan H., et al.
Publicado: (2021)

Factors related to the suppression of the antitumour immune response in female dogs with inflammatory mammary carcinoma
por: Damasceno, Karine Araújo, et al.
Publicado: (2022)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

CD56-Negative Extranodal NK/T-Cell Lymphoma, Nasal Type, with Extranasal Cutaneous Involvement
por: Kim, Hee Joo, et al.
Publicado: (2015)

Sharing different perspectives to understand asbestos‐induced carcinogenesis: A comment to Jiang et al. (2016)
por: Gualtieri, Alessandro Francesco
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b2mk5rdfugvmpeiqapr3nprb9r